Literature DB >> 21055652

Both high and low body mass indexes are prognostic risks in Japanese patients with chronic heart failure: implications from the CHART study.

Kotaro Nochioka1, Nobuyuki Shiba, Haruka Kohno, Masanobu Miura, Hiroaki Shimokawa.   

Abstract

BACKGROUND: Prognostic impact of body mass index (BMI) in Japanese patients with chronic heart failure (HF) remains unclear. METHODS AND
RESULTS: We examined the relationship between BMI and the prognosis of Japanese HF patients in the Chronic Heart Failure Analysis and Registry in the Tohoku District (CHART) study. The study sample was 972 Japanese chronic HF patients (mean age, 68.2 ± 13.5; male 65.2%). We categorized them into 5 groups; BMI <18.5, 18.5 to 22.9, 23.0 to 24.9 (reference), 25.0 to 29.9, and ≥ 30.0. Using a Cox hazards model, the relationships between BMI and deaths or admission for worsening HF were studied in detail. Mean follow-up period was 3.4 ± 1.7 years. Multivariate analysis showed that, as compared with reference group (BMI 23.0 to 24.9), hazard ratios (HR) for all-cause death showed a U-shaped association with 1.70 (95% confidence interval; 1.04-2.76), 1.23 (0.85-1.78), 1.26 (0.84-1.90), and 2.75 (1.51-5.00) among those with BMI<18.5, 18.5 to 22.9, 25.0 to 29.9, and ≥ 30.0, respectively. There were significant and suggestive U-shaped associations between BMI and cardiac-cause death or admission for worsening HF.
CONCLUSIONS: Both high and low BMIs were associated with increased outcomes, suggesting that extreme obesity is not beneficial in improving the prognosis of Japanese chronic HF patients.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 21055652     DOI: 10.1016/j.cardfail.2010.06.413

Source DB:  PubMed          Journal:  J Card Fail        ISSN: 1071-9164            Impact factor:   5.712


  9 in total

1.  Prognostic Value of Nutritional Indexes in Evaluating the 1-Year Results after Implantation of the Carillon Mitral Contour System.

Authors:  Hatice Tolunay; Salim Yasar; Serkan Asil; Erkan Yildirim; Ayse Saatci Yasar; Murat Celik; Uygar Cagdas Yuksel; Cem Barcin
Journal:  Acta Cardiol Sin       Date:  2022-05       Impact factor: 1.800

2.  Multimorbidity, guideline-directed medical therapies, and associated outcomes among hospitalized heart failure patients.

Authors:  Shinsuke Takeuchi; Takashi Kohno; Ayumi Goda; Yasuyuki Shiraishi; Masataka Kawana; Mike Saji; Yuji Nagatomo; Yosuke Nishihata; Makoto Takei; Shintaro Nakano; Kyoko Soejima; Shun Kohsaka; Tsutomu Yoshikawa
Journal:  ESC Heart Fail       Date:  2022-05-13

Review 3.  Obesity, inflammation, and heart failure: links and misconceptions.

Authors:  Filippos Triposkiadis; Andrew Xanthopoulos; Randall C Starling; Efstathios Iliodromitis
Journal:  Heart Fail Rev       Date:  2021-04-07       Impact factor: 4.214

4.  Clinical impacts of additive use of olmesartan in hypertensive patients with chronic heart failure: the supplemental benefit of an angiotensin receptor blocker in hypertensive patients with stable heart failure using olmesartan (SUPPORT) trial.

Authors:  Yasuhiko Sakata; Nobuyuki Shiba; Jun Takahashi; Satoshi Miyata; Kotaro Nochioka; Masanobu Miura; Tsuyoshi Takada; Chiharu Saga; Tsuyoshi Shinozaki; Masafumi Sugi; Makoto Nakagawa; Nobuyo Sekiguchi; Tatsuya Komaru; Atsushi Kato; Mitsumasa Fukuchi; Eiji Nozaki; Tetsuya Hiramoto; Kanichi Inoue; Toshikazu Goto; Masatoshi Ohe; Kenji Tamaki; Setsuro Ibayashi; Nobumasa Ishide; Yukio Maruyama; Ichiro Tsuji; Hiroaki Shimokawa
Journal:  Eur Heart J       Date:  2015-01-30       Impact factor: 29.983

5.  Cachexia research in Japan: facts and numbers on prevalence, incidence and clinical impact.

Authors:  Masaaki Konishi; Junichi Ishida; Jochen Springer; Stefan D Anker; Stephan von Haehling
Journal:  J Cachexia Sarcopenia Muscle       Date:  2016-04-12       Impact factor: 12.910

6.  Weight Loss in Obese Patients With Heart Failure.

Authors:  Elisabet Zamora; Carles Díez-López; Josep Lupón; Marta de Antonio; Mar Domingo; Javier Santesmases; María Isabel Troya; Crisanto Díez-Quevedo; Salvador Altimir; Antoni Bayes-Genis
Journal:  J Am Heart Assoc       Date:  2016-03-24       Impact factor: 5.501

7.  The presence of obesity paradox in Greek patients with chronic heart failure.

Authors:  Efstratios Vlaras; Konstantinos Giakoumidakis; Nikolaos V Fotos; Anastasia A Chatziefstratiou; Hero Brokalaki
Journal:  Pragmat Obs Res       Date:  2017-09-21

8.  Prognostic impacts of serum uric acid levels in patients with chronic heart failure: insights from the CHART-2 study.

Authors:  Takahide Fujihashi; Yasuhiko Sakata; Kotaro Nochioka; Masanobu Miura; Ruri Abe; Shintaro Kasahara; Masayuki Sato; Hajime Aoyanagi; Shinsuke Yamanaka; Hideka Hayashi; Takashi Shiroto; Koichiro Sugimura; Jun Takahashi; Satoshi Miyata; Hiroaki Shimokawa
Journal:  ESC Heart Fail       Date:  2020-12-30

9.  Adaptive servoventilation versus oxygen therapy for sleep disordered breathing in patients with heart failure: a randomised trial.

Authors:  Kimihiko Murase; Koh Ono; Tomoya Yoneda; Moritake Iguchi; Takafumi Yokomatsu; Tetsu Mizoguchi; Toshiaki Izumi; Masaharu Akao; Shinji Miki; Ryuji Nohara; Kenji Ueshima; Michiaki Mishima; Takeshi Kimura; David P White; Kazuo Chin
Journal:  Open Heart       Date:  2016-03-31
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.